Fri, December 2, 2022

Paul Knight Maintained (WST) at Buy with Decreased Target to $315 on, Dec 2nd, 2022

Paul Knight of Keybanc, Maintained "West Pharmaceutical Services, Inc." (WST) at Buy with Decreased Target from $350 to $315 on, Dec 2nd, 2022.

Paul has made no other calls on WST in the last 4 months.



There are 2 other peers that have a rating on WST. Out of the 2 peers that are also analyzing WST, all agree with Paul's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • John Sourbeer of "UBS" Initiated at Hold and Held Target at $250 on, Wednesday, November 30th, 2022
  • Derik De Bruin of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $250 on, Friday, October 28th, 2022